Literature DB >> 15767262

Rb enhances p160/SRC coactivator-dependent activity of nuclear receptors and hormone responsiveness.

Eric Batsché1, Julien Desroches, Steve Bilodeau, Yves Gauthier, Jacques Drouin.   

Abstract

The retinoblastoma tumor suppressor protein (Rb) is best known as a repressor of genes involved in cell cycle progression. Rb has also been implicated in activation of transcription, in particular by nuclear receptors (NRs) and by differentiation-related transcription factors, but the relevance of this activity is unclear. We show that Rb and the related proteins p107 and p130 enhance the activity of NRs related to NGFI-B (Nur factors) through direct interactions with NGFI-B and SRC-2. Although recruitment of SRC/p160 coactivators to the NGFI-B AF1 domain is independent of Rb, its presence enhances SRC-dependent transcription. Rb potentiation of SRC coactivators is exerted on a subset (Nur factors, hepatocyte nuclear factor-4 (HNF-4), SF-1, and ER) but not all NRs. The levels of Rb-related proteins modulate hormone responsiveness of the NGFI-B-dependent pituitary proopiomelanocortin gene and HNF-4-dependent transcription during enterocyte differentiation. Increased Rb expression upon cell differentiation may promote differentiated functions, at least in part, by potentiation of NR activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767262     DOI: 10.1074/jbc.M413428200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene.

Authors:  Ying Zhang; Mingjuan Liao; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

2.  The competence factor beta Ftz-F1 potentiates ecdysone receptor activity via recruiting a p160/SRC coactivator.

Authors:  Jinsong Zhu; Li Chen; Guoqiang Sun; Alexander S Raikhel
Journal:  Mol Cell Biol       Date:  2006-10-02       Impact factor: 4.272

Review 3.  The retinoblastoma tumor-suppressor gene, the exception that proves the rule.

Authors:  D W Goodrich
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

4.  Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease.

Authors:  Steve Bilodeau; Sophie Vallette-Kasic; Yves Gauthier; Dominique Figarella-Branger; Thierry Brue; France Berthelet; André Lacroix; Dalia Batista; Constantine Stratakis; Jeanette Hanson; Björn Meij; Jacques Drouin
Journal:  Genes Dev       Date:  2006-10-15       Impact factor: 11.361

5.  A pituitary-specific enhancer of the POMC gene with preferential activity in corticotrope cells.

Authors:  David Langlais; Catherine Couture; Guillaume Sylvain-Drolet; Jacques Drouin
Journal:  Mol Endocrinol       Date:  2010-12-30

6.  Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture.

Authors:  Markus Hassler; Shradha Singh; Wyatt W Yue; Maciej Luczynski; Rachid Lakbir; Francisco Sanchez-Sanchez; Thomas Bader; Laurence H Pearl; Sibylle Mittnacht
Journal:  Mol Cell       Date:  2007-11-09       Impact factor: 17.970

7.  Developmental dependence on NurRE and EboxNeuro for expression of pituitary proopiomelanocortin.

Authors:  Pierre-Luc Lavoie; Lionel Budry; Aurélio Balsalobre; Jacques Drouin
Journal:  Mol Endocrinol       Date:  2008-04-03

Review 8.  Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family.

Authors:  Jianming Xu; Ray-Chang Wu; Bert W O'Malley
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

9.  pRb is an obesity suppressor in hypothalamus and high-fat diet inhibits pRb in this location.

Authors:  Zhonglei Lu; Genevieve Marcelin; Frederick Bauzon; Hongbo Wang; Hao Fu; Siok Le Dun; Hongling Zhao; Xiaosong Li; Young-Hwan Jo; Sharon Wardlaw; Nae Dun; Streamson Chua; Liang Zhu
Journal:  EMBO J       Date:  2013-02-12       Impact factor: 11.598

10.  TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77.

Authors:  Juliette Rambaud; Julien Desroches; Aurélio Balsalobre; Jacques Drouin
Journal:  J Biol Chem       Date:  2009-03-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.